Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 8/20 | 0.73 |
| ▸ | MAPT | P10636 | 4/20 | 0.73 |
| ▸ | MEN1 | O00255 | 4/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.73 |
| ▸ | HTT | P42858 | 2/20 | 0.73 |
| ▸ | HPGD | P15428 | 2/20 | 0.73 |
| ▸ | RECQL | P46063 | 2/20 | 0.73 |
| ▸ | BLM | P54132 | 2/20 | 0.73 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.73 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.73 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.73 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | USP2 | O75604 | 2/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1030138 | 0.94 | MAPT (0.67) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL6508177 | 0.91 | FTO (0.70) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL6508174 | 0.90 | FTO (0.72) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL21638745 | 0.90 | FTO (0.72) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL19549132 | 0.89 | FTO (0.57) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL5872682 | 0.88 | FTO (0.89) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL28273623 | 0.88 | FTO (0.89) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL9844354 | 0.88 | FTO (0.89) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL19386225 | 0.88 | FTO (0.69) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL4663321 | 0.87 | FTO (0.82) | FTOMAPTMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 371 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3661539-B1 | OPTIMIZED PEPTIDES FOR TARGETING HUMAN NERVES AND THEIR USE IN IMAGE GUIDED SURGERY, DIAGNOSTICS AND THERAPEUTIC DELIVERY | UNIV CALIFORNIA (US) | 2024-10-09 | — | — | EP | claimed |
| US-20240207421-A1 | NERVE TARGETING PEPTIDES AND METHODS OF USE | ALUME BIOSCIENCES INC (US) | 2024-06-27 | — | — | US | claimed |
| CN-118103706-A | DHEAS assay, reagents for DHEAS assay, and methods of making and using the same | 美国西门子医学诊断股份有限公司 | 2024-05-28 | — | — | CN | claimed |
| US-11802138-B2 | Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostic and therapeutic delivery | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-31 | — | — | US | claimed |
| CN-116916971-A | Methods and compositions for ureter visualization in surgical procedures | 阿鲁莫生物科学公司 | 2023-10-20 | — | — | CN | claimed |
| US-20230257428-A1 | METHODS OF TREATMENT USING CHLOROTOXIN CONJUGATES | Blaze Bioscience, Inc. | 2023-08-17 | — | — | US | claimed |
| CN-116063472-A | anti-Spike S2 protein antibody and application thereof | 江苏东抗生物医药科技有限公司 | 2023-05-05 | — | — | CN | claimed |
| WO-2022155385-A1 | METHODS AND COMPOSITIONS FOR VISUALIZING A URETER IN A SURGICAL PROCEDURE | ALUME BIOSCIENCES, INC. (US) | 2022-07-21 | — | — | WO | claimed |
| WO-2022120177-A1 | NERVE TARGETING PEPTIDES AND METHODS OF USE | ALUME BIOSCIENCES, INC. (US) | 2022-06-09 | — | — | WO | claimed |
| US-11299515-B2 | Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-04-12 | — | — | US | claimed |
| US-8658037-B2 | Method for determining physiological state of microbial community and wastewater treatment method | SEIKO PMC CORPORATION (JP) | 2014-02-25 | — | — | US | claimed |
| US-20110100903-A1 | METHOD FOR DETERMINING PHYSIOLOGICAL STATE OF MICROBIAL COMMUNITY AND WASTEWATER TREATMENT METHOD | SEIKO PMC CORPORATION (JP) | 2011-05-05 | — | — | US | claimed |
| US-6696241-B2 | MEASURING ESTERASE ACTIVITY | THE REGENT OF THE UNIVERSITY OF CALIFORNIA | 2004-02-24 | — | — | US | claimed |
| US-20010049091-A1 | Use of fluorescent reagents in identification of cancerous cells and activated lymphocytes | THOMPSON JAMES (US) | 2001-12-06 | — | — | US | claimed |
| WO-2000003033-A9 | USE OF FLUORESCENT REAGENTS IN IDENTIFICATION OF CANCEROUS CELLS AND ACTIVATED LYMPHOCYTES | UNIV CALIFORNIA (US) | 2000-10-05 | — | — | WO | claimed |
| WO-2000003033-A1 | USE OF FLUORESCENT REAGENTS IN IDENTIFICATION OF CANCEROUS CELLS AND ACTIVATED LYMPHOCYTES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-01-20 | — | — | WO | claimed |
| EP-0267049-A2 | Method of determining endothelial cell coverage of a prosthetic surface | THOMAS JEFFERSON UNIVERSITY (US) | 1988-05-11 | — | — | EP | claimed |
| JP-56084786-A | — | — | None | — | — | JP | disclosed |
| EP-0267049-A2 | Method of determining endothelial cell coverage of a prosthetic surface | THOMAS JEFFERSON UNIVERSITY (US) | 1988-05-11 | — | — | EP | disclosed |
| JP-S5684786-A | REVERSIBLE TEMPERATURE-INDICATING MATERIAL | DAINIPPON PRINTING CO LTD | 1981-07-10 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257428-A1 | METHODS OF TREATMENT USING CHLOROTOXIN CONJUGATES | CHLSN, SLC47A1, CLSPN | FTO 3230/4885MAPT 2934/4885MEN1 1272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.